Allison Baur Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 65 Bryden St, Pittston, PA 18640 Phone: 570-225-9299 |
Tara Lyn Ahearn Simington, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 103 New St, Pittston, PA 18640 Phone: 570-954-0047 |
Ms. Deborah M Knecht Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 466 N Main St, Pittston, PA 18640 Phone: 570-299-0092 |
Antoinette Terrana, MA, PC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 22 Carey Ln, Pittston, PA 18640 Phone: 570-883-1042 |
News Archive
The U.S. Food and Drug Administration today approved Levaquin (levofloxacin) to treat patients with plague, a rare and potentially deadly bacterial infection. The agency also approved the drug to reduce the risk of getting plague after exposure to Yersinia pestis, the bacterium that causes the disease.
On Oct. 17, the U.S. Food and Drug Administration approved Jetrea (ocriplasmin), the first drug approved to treat an eye condition called symptomatic vitreomacular adhesion (VMA).
A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a conventional cord blood transplant procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 53rd American Society of Hematology Annual Meeting.
Kaiser Health News provides a fresh take on health policy developments with "Walking Wounded?" by Jimmy Margulies.
› Verified 1 days ago